Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

84.75

+0.05 (0.06%)

At close: Aug 17, 2026, 4:00 PM EDT

84.83

+0.08 (0.09%)

After-hours: Aug 17, 2026, 6:07 PM EDT

Crinetics Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	42.16	7.7	1.04	4.01	4.74	1.08
Revenue Growth	2928.45%	640.71%	-74.11%	-15.28%	339.43%	1418.31%
Cost of Revenue	376.88	333.13	240.16	168.53	130.23	84.26
Gross Profit	-334.72	-325.44	-239.12	-164.51	-125.49	-83.18
Selling, General & Admin	214.37	191.33	99.74	58.09	42.39	24.53
Operating Expenses	214.37	191.33	99.74	58.09	42.39	24.53
Operating Income	-549.09	-516.77	-338.85	-222.61	-167.88	-107.7
Interest & Investment Income	48.39	51.99	41.44	13.44	4.32	0.16
Earnings From Equity Investments	-	-	-0.47	-5.2	-1.01	-
Currency Exchange Gain (Loss)	-	-	-	-	-	-0.11
Other Non Operating Income (Expenses)	-0.73	-0.36	-0.52	-0.16	0.66	0.01
Pretax Income	-501.43	-465.14	-298.41	-214.53	-163.92	-107.64
Income Tax Expense	0.18	0.18	-	-	-	-
Net Income	-501.61	-465.32	-298.41	-214.53	-163.92	-107.64
Net Income to Common	-501.61	-465.32	-298.41	-214.53	-163.92	-107.64
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	100	94	81	58	52	38
Shares Outstanding (Diluted)	100	94	81	58	52	38
Shares Change	11.25%	16.43%	39.11%	11.71%	35.24%	26.24%
EPS (Basic)	-5.03	-4.95	-3.69	-3.69	-3.15	-2.80
EPS (Diluted)	-5.03	-4.95	-3.69	-3.69	-3.15	-2.80
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-425.18	-383.68	-234.04	-173.29	-116.86	-89.02
Free Cash Flow Per Share	-4.26	-4.08	-2.90	-2.98	-2.25	-2.32
Operating Margin	-1302.52%	-6714.77%	-32613.47%	-5547.17%	-3544.06%	-9990.91%
Profit Margin	-1189.88%	-6046.22%	-28720.69%	-5345.85%	-3460.38%	-9985.25%
Free Cash Flow Margin	-1008.58%	-4985.50%	-22525.31%	-4318.12%	-2466.98%	-8258.26%
EBITDA	-544.85	-512.88	-336.07	-221.51	-166.9	-106.78
D&A For EBITDA	4.24	3.89	2.79	1.1	0.98	0.92
EBIT	-549.09	-516.77	-338.85	-222.61	-167.88	-107.7
Revenue as Reported	42.16	7.7	1.04	4.01	-	-
Advertising Expenses	-	16.9	-	-	-	-

SEC Filings: 10-K · 10-Q